Treatments for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing data

FDA-approved treatments (1)

Patient support programs (1)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

Enspryng

Genentech, Inc.

Enspryng Patient Support (Genentech Access Solutions)

Patient Assistance
Manufacturer Program
Accepting applications
Apply

More about Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies